Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy
Pieter Martens1, Frederik H Verbrugge2, Petra Nijst1
1Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Doctoral School for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Insights
Older adults (octogenarians) receiving cardiac resynchronization therapy (CRT) experience significant symptomatic and remodeling benefits, with survival rates comparable to the general age-matched population.
Area of Science:
- Cardiology
- Geriatric Medicine
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is established for heart failure with reduced ejection fraction (HFrEF) and electrical dyssynchrony.
- Clinical CRT populations are typically older than those in clinical trials.
Purpose of the Study:
- To evaluate clinical response, reverse remodeling, outcomes, and causes of death in octogenarians undergoing CRT.
- Compare octogenarians with younger patients receiving CRT.
Main Methods:
- Retrospective analysis of 686 CRT patients, including 178 octogenarians.
- Assessed changes in NYHA class, ejection fraction, and ventricular dimensions.
- Compared heart failure readmissions, all-cause mortality, and mode of death.
- Compared octogenarian CRT mortality with age-matched general population data.
Main Results:
- Octogenarians showed similar improvements in NYHA class, ejection fraction, and ventricular size compared to younger patients.
- Octogenarians had higher all-cause mortality but similar heart failure readmission rates.
- Non-cardiac deaths were more prevalent in octogenarians; worsening heart failure was the primary cardiac cause of death.
- Octogenarians receiving CRT had an annual mortality rate equivalent to the age-matched general population.
Conclusions:
- Octogenarians benefit significantly from CRT, showing comparable symptomatic and remodeling responses to younger patients.
- Survival in octogenarians receiving CRT is similar to the general age-matched population.
- CRT is a viable treatment option for selected octogenarians with HFrEF and dyssynchrony.
Background:
Cardiac resynchronization therapy (CRT) improves morbidity and mortality in heart failure with reduced ejection fraction (HFrEF) and electrical dyssynchrony. CRT patients in clinical practice are older compared with clinical trials.
Objective:
To investigate clinical response, reverse remodeling, outcome, and mode of death in octogenarians receiving CRT.
Methods:
Baseline characteristics, change in New York Heart Association (NYHA) functional class, reverse ventricular remodeling, heart failure readmissions, all-cause mortality, and mode of death were evaluated in CRT patients with comparison between octogenarians and nonoctogenarians. In addition, annual mortality rates of octogenarians undergoing CRT were compared with age-matched control subjects from the general population with the use of national actuarial tables.
Results:
A total of 686 patients, including 178 octogenarians (26%), were followed for 38 ± 22 months. Octogenarians exhibited a similar change in NYHA functional class (P = .640), left ventricular ejection fraction increase (P = .796), and decrease in end-diastolic (P = .441) and end-systolic (P = .312) diameter compared with their younger counterparts undergoing CRT. Octogenarians had a higher all-cause mortality risk (P < .001), but heart failure readmission risk did not differ (hazard ratio 0.916, 95% confidence interval 0.638-1.313; P = .632). A higher proportion of noncardiac deaths was observed in octogenarians (74%) versus younger patients (50%; P = .022), with worsening heart failure rather than malignant tachyarrhythmia being the main cardiac cause of death. Compared with an age-matched sample from the general population, octogenarians receiving CRT had an equivalent annual mortality rate (log-rank test: P = .444).
Conclusions:
Octogenarians retain the ability to mount a significant symptomatic and ventricular remodeling response after CRT, resulting in survival similar to the general age-matched population.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure III: Clinical Manifestations
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology


